Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front Med Chin    2009, Vol. 3 Issue (2) : 227-229    https://doi.org/10.1007/s11684-009-0035-4
RESEARCH ARTICLE
A new thinprep cytologic test of cervical cells and its application
Xiaojun ZHAO, Jingjuan WEI, Rong WANG, Yajun GU, Yunde LIU()
Clinical Laboratory Science Department of Tianjin Medical University, Tianjin 300203, China
 Download: PDF(73 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

In order to improve the quality of routine cervical smears, we investigated the new Thinprep cytologic test (TCT) for cervical cells. In this study, 100 women who were enrolled were randomly divided into two groups. In one group, the TCT for cervical cells was applied (TCT group), and in the other group routine cervical smear was used. In addition, the cells in the TCT group were screened by double sifters, and centrifuged using a separation medium so as to eliminate mucus, inflammatory cells and blood cells. According to the cell distribution and the thickness of the smear, the results were assigned to three groups, including satisfactory smears, less satisfactory smears and unsatisfactory smears. The TCT had a higher satisfactory rate (98%) compared to the routine cervical smear (32%) (P<0.01), indicating the TCT was superior to the routine cervical smear. It is concluded that the TCT is more acceptable. Meanwhile, in comparison to the routine cervical smear, the TCT for cervical cells has 5 advantages which can greatly increase the cytological accuracy.

Keywords thinprep cytologic test      cervical cells      Papanicolaou smear     
Corresponding Author(s): LIU Yunde,Email:yundeliu@126.com   
Issue Date: 05 June 2009
 Cite this article:   
Xiaojun ZHAO,Jingjuan WEI,Rong WANG, et al. A new thinprep cytologic test of cervical cells and its application[J]. Front Med Chin, 2009, 3(2): 227-229.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-009-0035-4
https://academic.hep.com.cn/fmd/EN/Y2009/V3/I2/227
calcium propionatepotassium sorbatesodium benzoatecomplex compound
Cell destruction ++c+b+++d+b
bacteria proliferation++c++c++c+/-a
Tab.1  Results of cervical cells preserved for 3 weeks with 4 kinds of preserving fluid
cell distortion and destructioncell adhesion after centrifugationcell superpositioncell enrichmentimpurity separation in mucus
acids++c+++d+b++c+b
salts-a-a++c+b-a
saccharide-a-a-a+++d++c
mucussolvent++c+b+b++c-a
alcohols+b-a+++d++c+b
Tab.2  Comparison of the effectiveness of 5 kinds of separating medium
groupssatisfaction (n)less satisfaction (n)dissatisfaction (n)satisfactory rateP value
11629532%&lt;0.01
2482098%
Tab.3  Comparison of the effectiveness between groups 2 and 1
1 Li X M. Mental nursing of temple neck cancer patients operated. Shi Yong Yi Ji Za Zhi , 2006, 13(2): 279-280 (in Chinese)
2 Kuhn L, Denny L, Pollack A, Lorincz A, Richart R M, Wright T C. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer lnst , 2000, 92(10): 818-825
3 Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol , 2000, 19(1,2): 1-5
4 Pisani P, Bray F, Parkin D M. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. Int J Cancer , 2002, 97(1): 72-81
doi: 10.1002/ijc.1571
5 Zhang W Y, Xue Y Z, Chen M, Han L, Luo M. Prevalence of high-risk human papillomavirus infection in different cervical lesion among organized health-examination women in Shanghai, China. Chin Med J , 2008, 121(16): 1578-1582
6 Bray F, Sankila R, Ferlay J, Parkin D. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer , 2002, 38(1): 99-166
doi: 10.1016/S0959-8049(01)00350-1
7 Xu L Z. Retrospect and prospect of clinical oncocytological research. Aizheng , 2004, 23(12): 1717-1720 (in Chinese)
8 Papanicolaou G N, Traut H F. The diagnostic value of vaginal smears in carcinoma of the uterus. 1941. Arch Pathol Lab Med , 1997, 121(3): 211-224
9 Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N; Forum Group Members; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA , 2002, 287(16): 2114-2119
10 Lang J H. The chance to greed the global challenge to the cervical cancer prevention. Zhong Hua Fu Ke Za Zhi , 2002, 37(1): 1 (in Chinese)
11 Liu X Y, Feng F Y, Zhao S H. American Cancer Society guidelines for the early detection of cancer. Zhongguo Yikan , 2004, 39(7): 49-50 (in Chinese)
12 Shi P, Li J X, Zhang Y Z. Comparing the Conventional Papanicolaou Smear Test with liquid-based Cytology. Shanxi Yiyao Zazhi , 2004, 33(5): 423-425 (in Chinese)
13 Bray F, Loos A H, McCarron P, Weiderpass E, Arbyn M, M旿ller H, Hakama M, Parkin D M. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev , 2005, 14(3): 677-686
doi: 10.1158/1055-9965.EPI-04-0569
14 DeMay R M. Common problems in papanieolaou smear interpretatin. Arch Patho1 Lab Med , 1997, 12l(3): 229-238
15 Frable W J. Does a zero error standard exist for the papanicolaou smear? A pathologist’s perspective. Arch Pathol Lab Med , 1997, 121(3): 301-310
16 Hutchinson M L, Isenstein L M, Goodman A, Hurley A A, Douglass K L, Mui K K, Patten F W, Zahniser D J. Homogeneous sampling accounts for the increased diagnostic accuracy using the Thinprep Processor. Am J Clin Pathol , 1994, 101(2): 215-219
17 Sun G T. The advancement of the automation and normalization of the cervical cytological examination. Yixue Linchuang Yanjiu , 2003, 20(10): 782-785 (in Chinese)
18 Ronco G, Giorgi-Rossi P, Carozzi F, Dalla Palma P, Del Mistro A, De Marco L, De Lillo M, Naldoni C, Pierotti P, Rizzolo R, Segnan N, Schincaglia P, Zorzi M, Confortini M, Cuzick J; New Technologies for Cervical Cancer screening Working Group. Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial. Lancet Oncol , 2006, 7(7): 547-555
doi: 10.1016/S1470-2045(06)70731-8
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed